A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, anActinidia arguta(hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis

The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study

British Journal of Dermatology ◽

10.1111/bjd.20690 ◽

2021 ◽

Author(s):

Y. Zhao ◽

L. Wu ◽

Q. Lu ◽

X. Gao ◽

X. Zhu ◽

...

Keyword(s):

Atopic Dermatitis ◽

Chinese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Probiotics improve atopic dermatitis in children and adolescents: a double blind, placebo-controlled study.

10.22541/au.158930908.86661145 ◽

2020 ◽

Author(s):

Paula Danielle Santa Maria Albuquerque de Andrade ◽

Jorgete Maria e Silva ◽

Vanessa Carregaro ◽

La s Sacramento ◽

Luciana Roberti ◽

...

Keyword(s):

Atopic Dermatitis ◽

Children And Adolescents ◽

Controlled Study ◽

Double Blind ◽

Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2013.12.1068 ◽

2014 ◽

Vol 133 (2) ◽

pp. AB404 ◽

Cited By ~ 2

Author(s):

Thomas R.M. Bieber ◽

Diamant Thaci ◽

Neil Graham ◽

Gianluca Pirozzi ◽

Ariel Teper ◽

...

Keyword(s):

Atopic Dermatitis ◽

Controlled Study ◽

Double Blind ◽

Exploring the efficacy and safety of topical Jaungo application in patients with atopic dermatitis: A pilot randomized, double-blind, placebo-controlled study

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2018.07.007 ◽

2018 ◽

Vol 40 ◽

pp. 22-28 ◽

Cited By ~ 1

Author(s):

Jin Hyang Ahn ◽

Younghee Yun ◽

Min Hee Kim ◽

Seoung-Gyu Ko ◽

Kyu Seok Kim ◽

...

Keyword(s):

Atopic Dermatitis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

The oral Janus kinase/spleen tyrosine kinase inhibitorASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study

British Journal of Dermatology ◽

10.1111/bjd.17932 ◽

2019 ◽

Vol 181 (4) ◽

pp. 733-742 ◽

Cited By ~ 28

Author(s):

R. Bissonnette ◽

C. Maari ◽

S. Forman ◽

N. Bhatia ◽

M. Lee ◽

...

Keyword(s):

Atopic Dermatitis ◽

Tyrosine Kinase ◽

Systemic Inflammation ◽

Janus Kinase ◽

Controlled Study ◽

Spleen Tyrosine Kinase ◽

Double Blind ◽

Faculty Opinions recommendation of The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725811120.793513059 ◽

2016 ◽

Author(s):

Hidehisa Saeki

Keyword(s):

Atopic Dermatitis ◽

Single Dose ◽

Healthy Volunteers ◽

Controlled Study ◽

Double Blind ◽

Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Pivotal Phase 3, Randomised, Double-Blind, Placebo-Controlled Study (AD Up)

SSRN Electronic Journal ◽

10.2139/ssrn.3748383 ◽

2020 ◽

Author(s):

Kristian Reich ◽

Henrique D. Teixeira ◽

Marjolein de Bruin-Weller ◽

Thomas Bieber ◽

Weily Soong ◽

...

Keyword(s):

Atopic Dermatitis ◽

Controlled Study ◽

Phase 3 ◽

Pivotal Phase ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Topical Corticosteroids ◽

Adolescents And Adults

OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2016.04.001 ◽

2016 ◽

Vol 75 (2) ◽

pp. 297-305 ◽

Cited By ~ 46

Author(s):

Jon M. Hanifin ◽

Charles N. Ellis ◽

Ilona J. Frieden ◽

Regina Fölster-Holst ◽

Linda F. Stein Gold ◽

...

Keyword(s):

Atopic Dermatitis ◽

Phase Ii ◽

Pde4 Inhibitor ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Phosphodiesterase 4 ◽

Adolescent Patients

Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study

Artificial Cells Nanomedicine and Biotechnology ◽

10.1080/21691401.2019.1640709 ◽

2019 ◽

Vol 47 (1) ◽

pp. 3540-3547 ◽

Cited By ~ 1

Author(s):

Lunfei Liu ◽

Jisu Chen ◽

Jinhua Xu ◽

Qinping Yang ◽

Chaoying Gu ◽

...

Keyword(s):

Atopic Dermatitis ◽

Sublingual Immunotherapy ◽

Controlled Study ◽

Double Blind ◽

Lack of effect of mattress encasings on atopic dermatitis outcome measures in a double-blind placebo controlled study: Dutch mite avoidance study (DUMAS)

Journal of Allergy and Clinical Immunology ◽

10.1016/s0091-6749(02)81245-3 ◽

2002 ◽

Vol 109 (1) ◽

pp. S52-S52

Author(s):

AJ Oosting ◽

MS de Bruin-Weller ◽

I Terreehorst ◽

Z Tempels-Pavlica ◽

RC Aalberse ◽

...

Keyword(s):

Atopic Dermatitis ◽

Outcome Measures ◽

Controlled Study ◽

Double Blind ◽